Cancer52 is delighted to announce that Jonathan Pearce, chief executive of the Lymphoma Association, has been appointed as Chair of Cancer52, succeeding interim Chair Clara Mackay.
Said Clara: "I’m delighted to be handing over this role to Jonathan at such an important point in Cancer52’s development. I am confident that Cancer52 will greatly benefit from Jonathan’s passion and experience - and that the voice of rare and less common cancers will be well represented where and when it matters."
Jonathan’s appointment takes effect from 21 April 2015.